Alcohol and cardiovascular health: the dose makes the poison… or the remedy JH O’Keefe, SK Bhatti, A Bajwa, JJ DiNicolantonio, CJ Lavie Mayo Clinic Proceedings 89 (3), 382-393, 2014 | 478 | 2014 |
Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality JH O'Keefe, SK Bhatti, HR Patil, JJ DiNicolantonio, SC Lucan, CJ Lavie Journal of the American College of Cardiology 62 (12), 1043-1051, 2013 | 434 | 2013 |
The evidence for saturated fat and for sugar related to coronary heart disease JJ DiNicolantonio, SC Lucan, JH O’Keefe Progress in cardiovascular diseases 58 (5), 464-472, 2016 | 374 | 2016 |
Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis JJ DiNicolantonio, JH O’Keefe, W Wilson Open heart 5 (1), e000668, 2018 | 359 | 2018 |
Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials S Bangalore, H Makani, M Radford, K Thakur, B Toklu, SD Katz, ... The American journal of medicine 127 (10), 939-953, 2014 | 312 | 2014 |
L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis JJ DiNicolantonio, CJ Lavie, H Fares, AR Menezes, JH O'Keefe Mayo Clinic Proceedings 88 (6), 544-551, 2013 | 311 | 2013 |
Evidence from randomised controlled trials did not support the introduction of dietary fat guidelines in 1977 and 1983: a systematic review and meta-analysis Z Harcombe, JS Baker, SM Cooper, B Davies, N Sculthorpe, ... Open heart 2 (1), e000196, 2015 | 253 | 2015 |
Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes JJ DiNicolantonio, J Bhutani, JH O'Keefe Open heart 2 (1), e000327, 2015 | 243 | 2015 |
Added fructose: a principal driver of type 2 diabetes mellitus and its consequences JJ DiNicolantonio, JH O'Keefe, SC Lucan Mayo Clinic Proceedings 90 (3), 372-381, 2015 | 227 | 2015 |
Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus MF McCarty, JJ DiNicolantonio Progress in cardiovascular diseases 63 (3), 383, 2020 | 216 | 2020 |
Importance of maintaining a low omega–6/omega–3 ratio for reducing inflammation JJ DiNicolantonio, JH O’Keefe Open heart 5 (2), e000946, 2018 | 201 | 2018 |
Alcohol and CV health: Jekyll and Hyde J-curves EL O'Keefe, JJ DiNicolantonio, JH O'Keefe, CJ Lavie Progress in cardiovascular diseases 61 (1), 68-75, 2018 | 190 | 2018 |
Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes H Fares, JJ DiNicolantonio, JH O'Keefe, CJ Lavie Open heart 3 (2), e000473, 2016 | 180 | 2016 |
Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies AR Menezes, CJ Lavie, JJ DiNicolantonio, J O'Keefe, DP Morin, S Khatib, ... Mayo Clinic Proceedings 88 (4), 394-409, 2013 | 177 | 2013 |
Capsaicin may have important potential for promoting vascular and metabolic health MF McCarty, JJ DiNicolantonio, JH O'Keefe Open Heart 2 (1), e000262, 2015 | 164 | 2015 |
The wrong white crystals: not salt but sugar as aetiological in hypertension and cardiometabolic disease JJ DiNicolantonio, SC Lucan Open heart 1 (1), e000167, 2014 | 160 | 2014 |
Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol) JJ DiNicolantonio, CJ Lavie, H Fares, AR Menezes, JH O'Keefe The American journal of cardiology 111 (5), 765-769, 2013 | 158 | 2013 |
The importance of a balanced ω-6 to ω-3 ratio in the prevention and management of obesity AP Simopoulos, JJ DiNicolantonio Open heart 3 (2), e000385, 2016 | 150 | 2016 |
Sugar addiction: is it real? A narrative review JJ DiNicolantonio, JH O’Keefe, WL Wilson British journal of sports medicine 52 (14), 910-913, 2018 | 148 | 2018 |
Pentoxifylline for vascular health: a brief review of the literature MF McCarty, JH O'Keefe, JJ DiNicolantonio Open heart 3 (1), e000365, 2016 | 134 | 2016 |